Researchers
-
Ana Sánchez Escuredo
Nephrology
Phd -
Cristina Cabrera López
Nephrology
-
Isabel Bueno López
Nephrology
-
Isabel Giménez Torrecilla
Nephrology
-
Meritxell Ibernon Vilaró
Nephrology
Phd -
Neus Rodríguez Farré
Nephrology
-
Oana Rap
Nephrology
-
Pilar Ruiz Valverde
Nephrology
Contact the group
Form-
Bermejo S, González E, López-Revuelta K, Ibernon M, López D, Martín-Gómez A, Garcia-Osuna R, Linares T, Díaz M, Martín N, Barros X, Marco H, Navarro MI, Esparza N, Elias S , Coloma A, Robles NR, Agraz I, Poch E, Rodas L, Lozano V, Fernández B, Hernández E, Martínez MI, Stanescu RI, Moirón JP, García N, Goicoechea M, Calero F, Bonet J, Galceran JM, Liaño F, Pascual J, Praga M, Fulladosa X, Soler MJ. 303/20
Risk factors for non-diabetic renal disease in diabetic patients.
Clin Kidney J. 2020 Jan 3;13(3):380-388.
-
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer, P, Joseph A, Filippatos G, for the FIDELIO-DKD Investigators. (Ibernon M) 223/20
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
N Engl J Med. 2020 Dec 3;383(23):2219-2229
-
Ibernon M, Bueno I, Rodríguez-Farré N, Ruiz P, Sánchez A, Massó E, Rap O, Giménez I, Cabrera C. 318/20
The impact of COVID-19 in hemodialysis patients: Experience in a hospital dialysis unit.
Hemodial Int. 2020 Nov;25(2):205-213
Projects
-
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Prospective study to evaluate survival and quality of life in patients over 80 years old with chronic kidney disease: comparison of conservative treatment vs treatment with dialysis.
-
DISTRICT ATTORNEY:
Ana Sánchez
-
TYPE E:
PI
-
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Analysis of intoxications that require extrarenal purification,
-
DISTRICT ATTORNEY:
Neus Rodríguez
-
TYPE E:
PI
-
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Factor XI LICA to Reduce Thrombotic Events in End-Stage Renal Disease Patients on Hemodialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of BAY 2976217
-
DISTRICT ATTORNEY:
BAYER AG
-
TYPE E:
RD2015
-
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Prospective study to evaluate survival and quality of life in patients over 80 years old with chronic kidney disease: comparison of conservative treatment vs treatment with dialysis.
-
DISTRICT ATTORNEY:
Ana sanchez
-
TYPE E:
PINE TREE
-
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Analysis of intoxications that require extrarenal purification,
-
DISTRICT ATTORNEY:
Neus Rodríguez
-
TYPE E:
PINE TREE
-
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Factor XI LICA to Reduce Thrombotic Events in End-Stage Renal Disease Patients on Hemodialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of BAY 2976217
-
DISTRICT ATTORNEY:
BAYER AG
-
TYPE E:
RD2015
-
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
ENBiBA: European Nephrectomy Bio-Bank
-
DISTRICT ATTORNEY:
DIABETESITY WORKING GROUP
-
TYPE E:
PI
-
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
ENBiBA: European Nephrectomy Bio-Bank
-
DISTRICT ATTORNEY:
DIABETES WORKING GROUP
-
TYPE E:
PINE TREE
-
- Year 2017
- Sant Joan Despí Moisès Broggi Hospital
Non-interventional study to investigate the safety, effectiveness and adherence of Velphoro® in the short and long term in real life in patients with hyperphosphatemia undergoing hemodialysis (HD) or peritoneal dialysis (PD)
-
DISTRICT ATTORNEY:
Vifor Fresenius Medical Care Renal Pharma
-
TYPE E:
EPA
-
- Year 2017
- Sant Joan Despí Moisès Broggi Hospital
Double-blind, randomized, placebo-controlled study to evaluate the effect of SNF472 on the progression of cardiovascular calcification in addition to the reference treatment in patients with end-stage nephropathy (NT) undergoing hemodialysis (HD)
-
DISTRICT ATTORNEY:
Sanifit Laboratories
-
TYPE E:
RD2015
Lines of action
- Line of Research in Clinical Nephrology: A Study of Renal Progression Factors in Diabetic Nephropathy
- Dialysis Research Line
- Renal
